The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T. (Q34580385)

3 August 2017

title

The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T. (English)

1 reference

acute decompensated heart failure

3 August 2017

0 references

0 references

1 reference

1

Marco Metra

1 reference

3 August 2017

13

Livio Dei Cas

1 reference

3 August 2017

2

Savina Nodari

1 reference

3 August 2017

Giovanni Parrinello

3

1 reference

3 August 2017

Claudia Specchia

4

1 reference

3 August 2017

Loretta Brentana

5

1 reference

3 August 2017

Patrizia Rocca

6

1 reference

3 August 2017

Francesco Fracassi

7

1 reference

3 August 2017

Tania Bordonali

8

1 reference

3 August 2017

Patrizia Milani

9

1 reference

3 August 2017

Rossella Danesi

10

1 reference

3 August 2017

Giulia Verzura

11

1 reference

3 August 2017

Ermanna Chiari

12

1 reference

3 August 2017

publication date

18 June 2007

1 reference

European Journal of Heart Failure

3 August 2017

published in

1 reference

3 August 2017

volume

9

1 reference

3 August 2017

issue

8

1 reference

3 August 2017

page(s)

776-786

1 reference

Trends in hospitalization for heart failure in Scotland 1980-1990.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

NT-proBNP in heart failure: therapy decisions and monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

N-terminal pro-brain natriuretic peptide A new gold standard in predicting mortality in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

NT-ProBNP reduction percentage during admission for acutely decompensated heart failure predicts long-term cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Prognostic value of cardiac troponin T in patients with both acute and chronic stable congestive heart failure: comparison with atrial natriuretic peptide, brain natriuretic peptide and plasma norepinephrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

The Modification of Diet in Renal Disease (MDRD) equations provide valid estimations of glomerular filtration rates in patients with advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Risk stratification after hospitalization for decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Regression modelling strategies for improved prognostic prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

A new look at the statistical model identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Role of N-terminal pro-B-type natriuretic peptide in risk stratification in patients presenting in the emergency room

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Pathophysiologic targets in the early phase of acute heart failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Cardioprotection: a new paradigm in the management of acute heart failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

Amino-terminal pro-brain natriuretic Peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.05.007

10.1016/J.EJHEART.2007.05.007

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference